Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease - Test2 - elhamkhani - TriplyDB

Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease

Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease

http://www.wikidata.org/entity/Q28242852

about

The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study.Correlation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease.Relationship between expression of triggering receptor-1 on myeloid cells in intestinal tissue and intestinal barrier dysfunction in severe acute pancreatitis.Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells.Correlation between triggering receptor expressed on myeloid cells-1 and clinical disease activity in Chinese patients with ulcerative colitis.Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic marker of ventilator-associated pneumonia TREM-1 Promotes Pancreatitis-Associated Intestinal Barrier Dysfunction.TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.Sensor molecules in intestinal innate immunity against bacterial infections.Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infe Triggering receptor expressed on myeloid cells type 1 as a potential therapeutic target in sepsis.The TREM receptor family and signal integration.Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells.Caspase recruitment domain-containing sensors and adaptors in intestinal innate immunity.Blockade of CD354 (TREM-1) Ameliorates Anti-GBM-Induced Nephritis TREM and TREM-like receptors in inflammation and disease.Evaluation and Validation of the Detection of soluble Triggering Receptor Expressed on Myeloid Cells 1 by Enzyme-linked immunosorbent Assay.Tea polyphenols inhibit the activation of NF-κB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum.Effect of TREM-1 blockade and single nucleotide variants in experimental renal injury and kidney transplantation.Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis.Triggering receptor expressed on myeloid cells-1 and 2 in bronchoalveolar lavage fluid in pulmonary sarcoidosis.sTREM-1 in patients with chronic kidney disease on hemodialysis.Effect of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) Blockade in Rats with Cecal Ligation and Puncture (CLP)-Induced Sepsis.Utility of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as biomarker to predict therapeutic response to methotrexate in rheumatoid arthritis.Early elevated levels of soluble triggering receptor expressed on myeloid cells-1 in subarachnoid hemorrhage patients.Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease.

P2860

Q26862713-5856845F-DCE2-485B-A474-8E4A62549869 Q33709822-AEF5AAE3-9F6B-4191-BB91-FDE7845BF795 Q33822597-8056F6F1-53D0-4CE7-96D7-CC1621D4FDA2 Q34031855-8AFA5322-276F-4FA7-881E-F39F5BF980C8 Q34756285-1DB4DAEB-5B69-423C-ABD2-C31EA1F9E36A Q35480033-795D0A5E-2BE0-4BB7-8CDC-16DA1256D35C Q35608519-BAB7D070-D486-4EDE-8E02-ACDD8AE586E8 Q35961344-CE7F3766-BC12-478A-98B2-E7D4491A149C Q35987572-7DBCC654-9840-4332-923A-C57953826D1E Q36179953-B0050DB1-EF3C-43A5-A950-227D7BAB2EA8 Q36388846-6246D982-555D-4989-A422-0D9AED72C002 Q36392555-1ED13044-54AB-42B0-ADEB-AA5D38E6A8CC Q36583155-9B73F7F1-2A11-4350-B1F5-ED38FB19C189 Q36655903-253C4614-0EE6-4FB7-AA59-64B6CEEBEF59 Q36793296-36998E31-3696-437D-8F38-D094A725C788 Q36857289-9FA9157C-00DA-4B87-8742-9A3B3A74F23B Q36943037-AD7779C3-D23D-4DC5-8E4C-009DA5C6855A Q37297533-269D090D-0E7E-425F-A6FC-B2EEFD08CB84 Q40416307-0CB6B188-15F5-4647-84D2-0A0FEEFE9177 Q41267932-37FEC3AA-5AE6-4618-9015-8B3568DE16AC Q42028532-3D8A4999-659B-4D2C-9751-FB811F130A04 Q43269929-94239D3C-687C-4AB8-9DF9-7C682F211179 Q45207692-74D6EFA6-7601-46BB-B9CA-30D32D7A23E2 Q46363280-6DD3282C-B7DC-4804-837E-5F53283D84C9 Q46473174-84FCBF7B-A033-49F2-B8DA-D9ED3CAEE87A Q47709408-EE671FEB-EEEF-4E0A-BF15-42DEED3C4239 Q48296668-31412ACD-09EB-4ABC-8129-C4F378E1D34F Q53525319-C8615252-9C1E-4C8A-AEAB-37F2D1AC013F

P2860

Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease

http://www.wikidata.org/entity/Q28242852

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Role of soluble triggering rec ...... in inflammatory bowel disease

@ast

Role of soluble triggering rec ...... in inflammatory bowel disease

@en

Role of soluble triggering rec ...... in inflammatory bowel disease

@nl

type

label

Role of soluble triggering rec ...... in inflammatory bowel disease

@ast

Role of soluble triggering rec ...... in inflammatory bowel disease

@en

Role of soluble triggering rec ...... in inflammatory bowel disease

@nl

prefLabel

Role of soluble triggering rec ...... in inflammatory bowel disease

@ast

Role of soluble triggering rec ...... in inflammatory bowel disease

@en

Role of soluble triggering rec ...... in inflammatory bowel disease

@nl

P1433

Q28242852-29353B63-78CB-4E9B-96E8-D6B233261569

P1476

Q28242852-C85AB7F7-5B54-45F1-BCEF-790FE9D49BFC

P2093

Q28242852-0419A664-4BFD-497C-B62B-7B79E0A6119C

Q28242852-1FDAC217-C11E-4125-B387-50B0B0D7179E

Q28242852-204AFDEE-1912-455B-B751-01DE55580511

Q28242852-55357A48-4416-437C-BABB-C33DE5BA3443

Q28242852-7E9017C4-276A-4729-B294-FA711C612974

Q28242852-BC4B94DC-0867-4BF4-9772-402CE89E03B3

Q28242852-C876BF67-EF78-4BF7-8255-0D3DE467DE8D

Q28242852-CE69A3D4-BEC5-4166-AD5E-D40C01269CE7

P2860

Q28242852-02607BAC-1F28-49FA-B93C-8B1B78E81E07

Q28242852-0811E619-5F98-46A4-BB57-AE0F144EB43A

Q28242852-0A20B5A0-A91C-4C86-8F00-170EE1BE7A71

Q28242852-201F5DA8-3EDB-411F-9DFC-07F313608164

Q28242852-438C7DC5-AFB1-4535-BA88-17114E0532A4

Q28242852-64DFCA5F-3197-4A06-AEF2-1099930EDE32

Q28242852-709C84A5-9837-4507-8D6B-681CF246DFB3

Q28242852-74D30629-2C19-4429-B1BC-4A1A8E1F9D11

Q28242852-82ADDB37-A6CA-43DA-A08F-A7B72F470B7C

Q28242852-904C97FA-40C4-43C7-9741-77053191D079

P304

Q28242852-F6872DB6-683C-40EF-A483-0FE9A79F2FA2

P31

Q28242852-DEF5DFB6-00FB-41E7-A07F-B11AAE50C268

P3181

Q28242852-D74C7154-AE6B-439C-AA3C-7B88BD52DB64

P356

Q28242852-9A63B8D6-3882-454F-AB37-FDBA1D3CD510

P407

Q28242852-6ED1E81A-F6F3-4908-A6CE-4EE8ED178922

P433

Q28242852-2D79453B-2C1B-4CF4-A4BF-50517955907B

P478

Q28242852-A78928FA-D407-4035-BA02-D0ABDBEA784C

P577

Q28242852-0F454E89-8748-4B87-8688-D6C61589C770

P5875

Q28242852-F4E54518-7525-4A34-AF7B-A79DD891A71F

P698

Q28242852-2D16ADFA-CD67-4E82-8A02-481F011C2BC2

P921

Q28242852-8076056A-4A55-4447-B79B-72DC7302880C

Q28242852-85875134-03B6-460A-83EF-444CE8940CB5

P932

Q28242852-10534B91-2880-4A46-9074-2A790B3BBE54

P3181

P356

WJG.V12.I21.3416

P1433

World Journal of Gastroenterology

P1476

Role of soluble triggering rec ...... in inflammatory bowel disease

@en

P2093

Athanasios Archimandritis

http://www.w3.org/2001/XMLSchema#string

Dimitrios Tzivras

http://www.w3.org/2001/XMLSchema#string

Evangelos J Giamarellos-Bourboulis

http://www.w3.org/2001/XMLSchema#string

Helen Giamarellou

http://www.w3.org/2001/XMLSchema#string

Michalis Tzivras

http://www.w3.org/2001/XMLSchema#string

Pantelis Koutoukas

http://www.w3.org/2001/XMLSchema#string

Thomas Tsaganos

http://www.w3.org/2001/XMLSchema#string

Vassilios Koussoulas

http://www.w3.org/2001/XMLSchema#string

P2860

Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.

Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection.

Defects in mucosal immunity leading to ulcerative colitis.

Review article: Crohn's disease: monitoring disease activity.

Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials.

T-cell-induced mucosal damage in the intestine.

Involvement of innate immunity in the development of inflammatory and autoimmune diseases.

A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis.

Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease.

P304

3416-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2286457

http://www.w3.org/2001/XMLSchema#string

P356

10.3748/WJG.V12.I21.3416

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

298737686

http://www.w3.org/2001/XMLSchema#string

P698

16733861

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

4087875

http://www.w3.org/2001/XMLSchema#string